Universal Vision Biotechnology Co., Ltd. (TPEX:3218)

Market Cap	19.83B
Revenue (ttm)	4.18B
Net Income (ttm)	1.08B
Shares Out	84.72M
EPS (ttm)	12.70
PE Ratio	18.43
Forward PE	17.39
Dividend	7.00 (3.04%)
Ex-Dividend Date	Apr 18, 2024

Volume	202,685
Average Volume	179,454
Open	229.50
Previous Close	230.00
Day's Range	229.00 - 236.00
52-Week Range	193.50 - 307.00
Beta	0.87
RSI	71.66
Earnings Date	Mar 28, 2025

About TPEX:3218

Universal Vision Biotechnology Co., Ltd. operates a chain of eye care clinics in Taiwan and China. The company offers optical devices, glasses, lens, and vision aid products. It is also involved in leasing of medical devices. In addition, the company offers hospital management, optometric, and technical consultancy services, as well as provides medical and scientific prescription eyeglasses. Further, it offers sunglasses, fashionable and reading glasses, and progressive lenses for presbyopia. Additionally, the company provides contact lenses fo...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1992
• Employees: 401
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 3218

Financial Performance

In 2023, TPEX:3218's revenue was 4.08 billion, an increase of 16.83% compared to the previous year's 3.49 billion. Earnings were 1.05 billion, an increase of 22.88%.